Bio-Rad Laboratories, Inc. (BIO)
292.42
-1.27
(-0.43%)
USD |
NYSE |
Feb 12, 16:00
253.60
-38.82
(-13.28%)
Pre-Market: 08:10
Bio-Rad Laboratories Cash from Investing (Quarterly) : -43.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp. | -23.80M |
| Azenta, Inc. | 36.77M |
| Harvard Bioscience, Inc. | -0.348M |
| Bionano Genomics, Inc. | -4.669M |
| Avantor, Inc. | -39.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 120.90M |
| Cash from Financing (Quarterly) | -52.50M |
| Free Cash Flow | 336.76M |
| Free Cash Flow Per Share (Quarterly) | 3.313 |
| Free Cash Flow to Equity (Quarterly) | 100.40M |
| Free Cash Flow to Firm (Quarterly) | 98.96M |
| Free Cash Flow Yield | 4.18% |